Paid-members only Regulations HOT TAKE: With lawsuits percolating in the background, CAP, Congress and others start working on VALID 2.0
Paid-members only FDA Just when you thought you might be safe, FDA sticks its nose into MRD testing (again)
Paid-members only Molecular Testing At-home testing companies were put on notice with FDA's most recent warning letter to Molecular Testing Labs
Paid-members only Start-Upomics Tempus' good very bad week included a $410m IPO, a lawsuit and a ~$20 swing in their post-IPO stock price
